hotspot -WSS

hotspot

author：comprehensive 2025-09-27 23:53:58 - browse：37576

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Results on Novartis prostate cancer therapy could expand its use

knowledge

WSS

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Wegovy’s successful heart trial raises vital question about weight loss

Naloxone nonprofit donates 200,000 doses after FDA approval

Health tech investors get more selective as pandemic boom fades

Friends ask where James Watson's attitudes about race came from

For Cytokinetics, FDA rejection of heart drug would help, not hinder

knowledge

hotspot

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What to know about Virgin Galactic's 1st mission taking paying customers to space

After affirmative action ruling, medical educators look to 'holistic review'

STAT Summit: Meghan O’Rourke on making chronic illness visible

After affirmative action ruling, medical educators look to 'holistic review'

A biotech analyst on neuroscience, placebo effect, not over

United colonoscopy coverage change 'may cost lives,' doctors say

Results on Novartis prostate cancer therapy could expand its use

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA clears Verve to begin U.S. study of gene

knowledge

Emergent cuts jobs, executive role in business shake

American woman, child freed after being kidnapped in Haiti last month

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Why a market frenzy over new weight loss drugs defies logic

UnitedHealth, Optum discontinue NaviHealth name

Wegovy trial has doctors encouraged over new possibilities

knowledge

hotspot

hotspot

hotspot